Voloridge Investment Management
TARS icon

Voloridge Investment Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Voloridge Investment Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,363
Closed -$1.91M – 1279
2025
Q4 		$1.91M Sell
23,363
-35,464
-60% -$2.65M 0.01% 926
2025
Q3 		$3.5M Buy
58,827
+214
+0.4% +$10.5K 0.01% 827
2025
Q2 		$2.37M Buy
+58,613
New +$2.64M 0.01% 921
2024
Q3 		– Sell
-27,827
Closed -$756K – 1355
2024
Q2 		$756K Buy
+27,827
New +$936K ﹤0.01% 1089

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Voloridge Investment Management's TARS Position: Q1 2026 in Review

Voloridge Investment Management sold out of Tarsus Pharmaceuticals (TARS) in Q1 2026, closing a stake of 23,363 shares — an estimated $1.91M sold.

Voloridge Investment Management first reported a position in TARS in Q2 2024 and held it in 4 quarters. The position peaked at $3.5M in Q3 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Voloridge Investment Management reported no remaining Tarsus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 23,363 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $1.91M.
  • Voloridge Investment Management first reported a position in Tarsus Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Voloridge Investment Management's Tarsus Pharmaceuticals position peaked at $3.5M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.